Intravitreal bevacizumab for peripapillary choroidal neovascular membranes

Andrew S Davis; James C Folk; Stephen R Russell; Elliott H Sohn; H Culver Boldt; Edwin M Stone; Vinit B Mahajan

doi:10.1001/archophthalmol.2012.465

Back

Intravitreal bevacizumab for peripapillary choroidal neovascular membranes

Journal article

Open access

Peer reviewed

Intravitreal bevacizumab for peripapillary choroidal neovascular membranes

Andrew S Davis, James C Folk, Stephen R Russell, Elliott H Sohn, H Culver Boldt, Edwin M Stone and Vinit B Mahajan

Archives of ophthalmology (1960), Vol.130(8), pp.1073-1075

08/2012

DOI: 10.1001/archophthalmol.2012.465

PMID: 22893085

Files and links (1)

url

https://doi.org/10.1001/archophthalmol.2012.465View

Published (Version of record) Open Access

Abstract

Peripapillary choroidal neovascularization (PCNV) can result in significant vision loss due to extension of blood or fluid into the macula.1,2 Treatment options for PCNV have included laser photocoagulation, subretinal surgery, and photodynamic therapy.1,3,4 More recently, the use of intravitreal anti–vascular endothelial growth factor antibodies has emerged as the optimal treatment for macular CNV due to age-related macular degeneration, presumed ocular histoplasmosis, myopia, angioid streaks, and traumatic choroidal rupture,5,6 but clinical trials almost exclusively included patients with subfoveal CNV. The purpose of this study was to review cases of PCNV treated with intravitreal bevacizumab.

Choroidal Neovascularization - diagnosis

Intravitreal Injections

Tomography, Optical Coherence

Humans

Middle Aged

Male

Treatment Outcome

Vascular Endothelial Growth Factor A - antagonists & inhibitors

Macular Degeneration - diagnosis

Macular Degeneration - drug therapy

Bevacizumab

Retreatment

Angiogenesis Inhibitors - administration & dosage

Antibodies, Monoclonal, Humanized - administration & dosage

Choroidal Neovascularization - drug therapy

Subretinal Fluid

Aged, 80 and over

Adult

Female

Aged

Visual Acuity - physiology

Fluorescein Angiography

Details

Title: Subtitle: Intravitreal bevacizumab for peripapillary choroidal neovascular membranes
Creators: Andrew S Davis
James C Folk
Stephen R Russell
Elliott H Sohn
H Culver Boldt
Edwin M Stone
Vinit B Mahajan
Resource Type: Journal article
Publication Details: Archives of ophthalmology (1960), Vol.130(8), pp.1073-1075
DOI: 10.1001/archophthalmol.2012.465
PMID: 22893085
NLM abbreviation: Arch Ophthalmol
ISSN: 0003-9950
eISSN: 1538-3601
Publisher: American Medical Association; United States
Language: English
Date published: 08/2012
Academic Unit: Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Ophthalmology and Visual Sciences
Record Identifier: 9983979980302771

Metrics

21 Record Views

8 Times Cited - Web of Science